BrainStorm Cell Therapeutics, Inc. (BCLI.OB) Receives Funding for ALS Research
Source: http://Blog.QualityStocks.net/?p=17400Posted on Monday, August 24th, 2009 | In Market Commentary, Small & Micro Cap
Today, leading developer of adult stem cell technologies BrainStorm Cell Therapeutics Inc. announced that it has secured the necessary funding to complete pre-clinical trials for treatments of ALS (Amyotrophic Lateral Sclerosis, also known as Lou Gehrig’s disease). The funding includes a prestigious grant from the Israeli government’s Office of the Chief Scientist (OCS) as well as a private investment.
CEO of BrainStorm, Rami Efrati, stated, “We are very gratified to receive these financial votes of confidence in our breakthrough stem cell technology. The new funding will enable us to complete our pre-clinical studies in ALS and meet our goal of beginning clinical studies in the coming year.”
The non-equity OCS grant totals $450,000 and marks the third consecutive year BrainStorm has received the award. Previously, the company received OCS grants totaling $798,000. BrainStorm’s royalty obligations to the OCS are capped at the amount of the grant received from the OCS.
Additionally, ACCBT Corporation, a private company that invests in biotechnology, announced that it will give an additional investment of about $1 million in BrainStorm. The new funding will comprise monthly tranches of $50,000 or more. ACCBT, under the control of BrainStorm’s president Chaim Lebovits, has previously invested more than $4 million in the company. ACCBT will receive shares of common stock from the company at a price of $0.12 per share and warrants for $0.29.
Mr. Lebovits commented, “The promising study results we have seen so far make me confident that the company, with G-D’s help, will be able to rapidly progress to a therapy for the unmet medical need of devastating neurodegenerative conditions like ALS.”
The company expects to begin Phase I clinical studies in 2010.
Let us hear your thoughts below:
Last 5 posts by QualityStocks
- Some Options as the US Dollar Continues its Slide - November 24th, 2009
- Newport Digital Technologies (NPDT.OB) Has a Competitive Edge - November 24th, 2009
- Small Cap Voice Featured Company: DecisionPoint Systems, Inc. (DNPI.OB) - November 24th, 2009
- Small Cap Voice Featured Company: Hitor Group, Inc. (HITR.OB) - November 24th, 2009
- Novavax, Inc. (NVAX) Prices Offering Of Common Stock - November 24th, 2009
ACCBT Corporation, adult stem cell, adult stem cell technologies, ALS, amyotrophic lateral sclerosis, Biotechnology, Brainstorm Cell Therapeutics Inc.;, ceo, Chaim Lebovits;, Israeli government, Lou Gehrig, Market Commentary, Office of the Chief Scientist, president, Rami Efrati, Small & Micro Cap, stem cell technology;, USD
 About QualityStocks (http://QualityStocks.net)
Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis. Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.